Understanding The Metaxin Complex: A Protein Involved in Cell Cycle Regulation and Cancer Development

Target Name: Metaxin complex

NCBI ID: P17818

Metaxin complex

Other Name(s): None

Understanding The Metaxin Complex: A Protein Involved in Cell Cycle Regulation and Cancer Development

Metaxin complex is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidney. It is a key regulator of the cell cycle and has been implicated in the development and progression of various diseases, including cancer. Despite its potential as a drug target or biomarker, metaxin complex has not yet received widespread attention from the scientific community.

The Metaxin Complex

The metaxin complex is a protein that consists of five subunits: MATN1, MATN2, MATN3, MATN4, and MATN5. These subunits are held together by multiple non-covalent interactions, including a disulfide bond and a hydrophobic effect. The MATN subunits contain a nucleotide-binding oligomerization (NBO) domain, which is responsible for the interaction with DNA and for the regulation of the cell cycle.

The metaxin complex plays a central role in the regulation of the cell cycle and the maintenance of cellular order. It is involved in the transition of cells from the G1 phase to the S/G2 phase of the cell cycle, as well as the regulation of mitosis and meiosis. The complex is also involved in the regulation of the actin cytoskeleton and in the organization of the mitotic spindle.

In addition to its role in the cell cycle, the metaxin complex is also implicated in the development and progression of various diseases, including cancer. For example, studies have shown that metaxin complex is overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. This overexpression is associated with the development of cancer-promoting effects, such as increased cell proliferation and the formation of cancer-initiating clone-like structures.

Despite its potential as a drug target or biomarker, metaxin complex has not yet received widespread attention from the scientific community. There are only a few studies that have investigated its role in the regulation of the cell cycle and its potential as a drug target.

One potential mechanism by which metaxin complex could be targeted as a drug is through its role in the regulation of the cell cycle. By inhibiting the activity of the metaxin complex, it may be possible to induce cell cycle arrest and prevent the formation of cancer-promoting structures. Additionally, the complex may be targeted by drugs that target the NBO domain, which is responsible for the interaction with DNA.

Another potential mechanism by which metaxin complex could be targeted as a drug is through its role in the regulation of the actin cytoskeleton. By modulating the organization of the actin filament, it may be possible to alter the mechanical forces that drive the actin cytoskeleton and potentially lead to the formation of cancer-promoting structures.

In conclusion, the metaxin complex is a protein that is involved in the regulation of the cell cycle and has been implicated in the development and progression of various diseases, including cancer. Despite its potential as a drug target or biomarker, the complex has not yet received widespread attention from the scientific community. Further research is needed to fully understand its role in the regulation of the cell cycle and its potential as a drug.

Protein Name: Metaxin Complex

The "Metaxin complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Metaxin complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets